Future Directions in Menopause Research: Optimizing Midlife Health of Women Roundtable

Date and Time

– May 16, 2024, 12:45 PM EDT

Save the Date.

Virtual Only

Event Information

“The Future Directions in Menopause Research: Optimizing Midlife Health of Women Roundtable” is the launch event for NIH’s Women’s Health Roundtable Series on important women’s health topics as part of the White House Women’s Health Research Initiative. This series was developed as a recommended action in response to the Presidential Memorandum to bring attention to priority topics within the Department of Health and Human Services and disseminate information on federally supported research areas. The roundtable series will be led by NIH institute, center, and office leadership and will engage the research community and the public to bring greater awareness to female-specific health conditions (e.g., menopause and endometriosis), as well as diseases and conditions that predominantly affect women (e.g., autoimmune diseases), and present or progress differently in women (e.g., heart disease, Alzheimer’s disease, etc.).

This launch event will be hosted by the NIH Office of Research on Women’s Health (ORWH) and the Office of Disease Prevention (ODP). This roundtable aims to inform and spark dialogue around the science on menopause and highlight NIH-supported work in the menopausal research domain. It also furthers initiatives outlined within the Executive Order on Advancing Women’s Health Research and Innovation to identify and explore gaps in women’s health and diseases and conditions that arise during women’s midlife and later years.

Please join us to hear remarks from ORWH Director Janine Austin Clayton, M.D., FARVO; NIH Director Monica M. Bertagnolli, M.D.; and ODP Director David M. Murray, Ph.D. Following these remarks will be a panel discussion on how NIH and the extramural community can galvanize research and charter new paths to address unanswered questions on women’s midlife health.





11:00–11:05 a.m.


Call to Order and Announcement of Upcoming Funding Priorities


Vivian Ota Wang, Ph.D., FACMG, CGC
Deputy Director, Office of Research on Women’s Health (ORWH), NIH


11:05–11:20 a.m.


ORWH Director’s Introduction of the Future Directions in Menopause Research Event, Menopause Roundtable, and 
Dr. Monica Bertagnolli and
Dr. David Murray


Janine Austin Clayton, M.D., FARVO
Associate Director for Research on Women’s Health, NIH
Director, ORWH, NIH


11:20–11:30 a.m.


Introductory Remarks Regarding the Future Direction of Menopause Research


Monica M. Bertagnolli, M.D.
Director, NIH


11:30–11:45 a.m.


Remarks on the Upcoming Pathways
to Prevention Workshop on the
Management of Menopause Symptoms


David M. Murray, Ph.D.
Associate Director for Prevention
Director, Office of Disease Prevention


11:45–11:50 a.m.


Introduction of Optimizing Midlife Health of Women Roundtable


Sarah M. Temkin, M.D.
Associate Director for Clinical Research, ORWH, NIH

Chhanda Dutta, Ph.D.
Chief, Clinical Gerontology Branch,
National Institute on Aging

11:50 a.m.–12:40 p.m.


Panel: Optimizing Midlife Health of Women Roundtable



Susan D. Reed, M.D., M.P.H., M.S.
Professor Emeritus, Past Vice Chair for Research,
Department of Obstetrics and Gynecology, University of Washington School of Medicine

Hadine Joffe M.D., M.Sc.
Paula A. Johnson, M.D., Professor of Psychiatry in the Field of Women's Health,
Harvard Medical School

Samar R. El Khoudary, Ph.D., M.P.H., FAHA
Professor, Vice Chair for Education,
Epidemiology and Clinical and Translation Science Institute,
University of Pittsburgh

12:40–12:45 p.m.


Closing Statement


Janine Austin Clayton, M.D., FARVO


Special Accommodations

Sign language interpreting services are available upon request. Individuals who need interpreting services and/or other reasonable accommodations to participate in this event should email kathryn.koczot@nih.gov, winseckk@mail.nih.gov, and engeljo@od.nih.gov. Requests should be made at least five business days in advance of the event.